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  In 2 patients with benign pエostatic hyperplasia， plas皿a testosterone levels decrea＄ed 4
weeks after administration of 300 mg／week， i，m．， of 17a－hydroxy－19－norprogesterone caproate
（SH－582）．




























        測 定 方 法






の分離にはBush A systemのpaper chromato－
graphyを用い5時間展開し， MtOHにて抽出し，
その1／5量で回収率を測定，残りの4／5量を乾固し，







































Table 2． Changes in 17－KS，
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Fig． 2． Percentage of pre－treatment values
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Fig． ’1． Plasma testosterone levels following
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